O=C1c2ccccc2C(=O)N1CCc1c(-c2[nH]c3ccccc3c2CCN2C(=O)c3ccccc3C2=O)[nH]c2ccccc12
The rule of three is typically followed by orally active drugs, which have a molecular weight of <300, a c LogP of ≤3, a hydrogen bond donor count of ≤3 and a hydrogen bond acceptor count of ≤3. Does the molecule comply with the rule of three?